Opioid Quantity Limit Overrides

Indications for Prior Authorization

Criteria

Authorization will be issued for long-term therapy. *For oral fentanyl products, please refer to the drug-specific quantity limit override criteria in the “Oral Fentanyl Products” guideline.

Administrative

Length of Approval: 5 Year(s)
For diagnosis of For Malignant Cancer Pain

  • In the absence of an opioid-specific quantity limit override guideline, the following approval criteria will be used:
    • Diagnosis of malignant (cancer) pain*

Administrative

Length of Approval: 1 Year(s)
For diagnosis of For Non-Malignant Pain

  • In the absence of an opioid-specific quantity limit override guideline, the following approval criteria will be used:
    • Prescribed by a pain specialist or by pain management consultation
    • AND
    • The prescriber maintains and provides chart documentation of the patient’s evaluation, including all of the following:
      • An appropriate patient medical history and physical examination
      • A description of the nature and intensity of the pain
      • Documentation of appropriate dose escalation
      • Documentation of ongoing, periodic review of the course of opioid therapy
      • An updated, comprehensive treatment plan (the treatment plan should state objectives that will be used to determine treatment success, such as pain relief or improved physical and/or psychosocial function)
      • Verification that the risks and benefits of the use of the controlled substance have been discussed with the patient, significant other(s), and/or guardian
P & T Revisions

2024-11-06, 2023-10-19, 2022-10-19, 2022-01-14, 2021-10-28, 2021-09-28, 2021-05-21, 2020-10-29, 2019-10-29


  • 2024-11-06: 2024 Annual Review. No criteria changes.
  • 2023-10-19: Annual review
  • 2022-10-19: Annual review
  • 2022-01-14: Annual Review
  • 2021-10-28: Annual Review
  • 2021-09-28: Addition of EHB formulary to guideline, no changes to criteria
  • 2021-05-21: Addition of EHB formulary to guideline, no changes to criteria
  • 2020-10-29: UM annual review.
  • 2019-10-29: 2019 Annual Review